In ccRCC, FOXK2 mRNA and protein levels were downregulated, and low FOXK2 expression was associated with worse disease-free survival, highlighting the potential of FOXK2 as an independent prognostic marker (60). The gene discussed is FOXK2; the disease is nonpapillary renal cell carcinoma.